LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
RESIGNATION OF NON-EXECUTIVE DIRECTOR
2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2023 ANNUAL REPORT
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
VOLUNTARY ANNOUNCEMENT - THE FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF M701, A BISPECIFIC ANTIBODY FOR TREATMENT OF MALIGNANT ASCITES
VOLUNTARY ANNOUNCEMENT - THE FIRST PATIENT ENROLLED IN PHASE II CLINICAL TRIAL OF M701, A BISPECIFIC ANTIBODY FOR TREATMENT OF MALIGNANT PLEURAL EFFUSION
Date of Board Meeting
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024